Search research articles
Contact Us
Filters
Showing results (661-670 of 771) with videos related to
Page
of 78
Sort By:
Transplant Immunology
|
December 2, 2006
Knockdown of mouse VCAM-1 by vector-based siRNA
A K M Shamsul Alam, Oliver Florey, Michele Weber, et al.
Diabetes, Obesity & Metabolism
|
February 8, 2020
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME
Subodh Verma, Qiuhe Ji, Deepak L Bhatt, et al.
Arthritis and Rheumatism
|
September 29, 2011
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis
Panagiotis Kamperidis, Tahereh Kamalati, Mathieu Ferrari, et al.
Circulation. Cardiovascular Imaging
|
October 8, 2009
Adenosine stress 64- and 256-row detector computed tomography angiography and perfusion imaging: a pilot study evaluating the transmural extent of perfusion abnormalities to predict atherosclerosis causing myocardial ischemia
Richard T George, Armin Arbab-Zadeh, Julie M Miller, et al.
Journal of the American Heart Association
|
June 14, 2021
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport
Richard T George, Liron Abuhatzira, Susan M Stoughton, et al.
European Journal of Heart Failure
|
December 11, 2019
Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial
Michael Böhm, Jonathan Slawik, Martina Brueckmann, et al.
Alcoholism, Clinical and Experimental Research
|
January 13, 2015
Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients
Primavera A Spagnolo, Vijay A Ramchandani, Melanie L Schwandt, et al.
Diabetes Care
|
December 6, 2017
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E Inzucchi, Bernard Zinman, David Fitchett, et al.
Alcoholism, Clinical and Experimental Research
|
September 8, 2011
The biometric measurement of alcohol consumption
Lawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Frontiers in Immunology
|
July 9, 2026
Delving into the innate and adaptive immunity of camelids: a paradigm of interspecies adaptation and evolutionary innovation
Remya Pg Ramesh, Avinash Premraj, Hadida Yasmin, et al.
Page
of 78
Search research articles
Search
Showing results (661-670 of 771) with videos related to
Sort By:
Page
of 78
Transplant Immunology
|
December 2, 2006
Knockdown of mouse VCAM-1 by vector-based siRNA
A K M Shamsul Alam, Oliver Florey, Michele Weber, et al.
Diabetes, Obesity & Metabolism
|
February 8, 2020
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME
Subodh Verma, Qiuhe Ji, Deepak L Bhatt, et al.
Arthritis and Rheumatism
|
September 29, 2011
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis
Panagiotis Kamperidis, Tahereh Kamalati, Mathieu Ferrari, et al.
Circulation. Cardiovascular Imaging
|
October 8, 2009
Adenosine stress 64- and 256-row detector computed tomography angiography and perfusion imaging: a pilot study evaluating the transmural extent of perfusion abnormalities to predict atherosclerosis causing myocardial ischemia
Richard T George, Armin Arbab-Zadeh, Julie M Miller, et al.
Journal of the American Heart Association
|
June 14, 2021
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport
Richard T George, Liron Abuhatzira, Susan M Stoughton, et al.
European Journal of Heart Failure
|
December 11, 2019
Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial
Michael Böhm, Jonathan Slawik, Martina Brueckmann, et al.
Alcoholism, Clinical and Experimental Research
|
January 13, 2015
Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients
Primavera A Spagnolo, Vijay A Ramchandani, Melanie L Schwandt, et al.
Diabetes Care
|
December 6, 2017
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E Inzucchi, Bernard Zinman, David Fitchett, et al.
Alcoholism, Clinical and Experimental Research
|
September 8, 2011
The biometric measurement of alcohol consumption
Lawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Frontiers in Immunology
|
July 9, 2026
Delving into the innate and adaptive immunity of camelids: a paradigm of interspecies adaptation and evolutionary innovation
Remya Pg Ramesh, Avinash Premraj, Hadida Yasmin, et al.
Page
of 78